Hemostemix is a public clinical-stage company that develops innovative blood-derived cell therapies
Location: Canada, Alberta, Calgary
Member count: 11-50
Founded date: 2006
Investors 1
| Date | Name | Website |
| - | Biobrit | biobrit.co... |
Mentions in press and media 26
| Date | Title | Description | Category | Author | Source |
| 02.05.2023 | Hemostemix... | Calgary, Alberta--(Newsfile Co... | - | - | einpresswi... |
| 23.01.2023 | Investment... | - | - | - | globenewsw... |
| 04.02.2022 | Hemostemix... | Hemostemix Announces Financing... | - | - | marketscre... |
| 28.10.2021 | Hemostemix... | Hemostemix Confirms OTCQB List... | - | - | marketscre... |
| 19.10.2021 | Hemostemix... | Hemostemix Confirms its OTCQB ... | - | - | marketscre... |
| 14.10.2021 | Hemostemix... | Hemostemix Announces Dr. Frase... | - | - | marketscre... |
| 05.10.2021 | Hemostemix... | Hemostemix Announces the Secon... | - | - | marketscre... |
| 05.10.2021 | Hemostemix... | Hemostemix Announces Five Mill... | - | - | marketscre... |
| 21.09.2021 | Hemostemix... | Hemostemix Announces Closing o... | - | - | marketscre... |
| 14.09.2021 | Hemostemix... | Calgary, Alberta--(Newsfile Co... | - | - | marketscre... |
Show more